Crossmark Global Holdings’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.61M Buy
13,589
+160
+1% +$18.5K 0.02% 517
2026
Q1
$1.6M Sell
13,429
-110
-0.8% -$14.4K 0.02% 484
2025
Q4
$1.84M Buy
13,539
+1,897
+16% +$273K 0.03% 451
2025
Q3
$1.72M Buy
11,642
+3
+0% +$416 0.03% 491
2025
Q2
$1.51M Sell
11,639
-432
-4% -$52.3K 0.02% 505
2025
Q1
$1.44M Sell
12,071
-347
-3% -$43K 0.03% 500
2024
Q4
$1.44M Sell
12,418
-98
-0.8% -$12.4K 0.03% 477
2024
Q3
$1.69M Sell
12,516
-343
-3% -$45.9K 0.03% 450
2024
Q2
$1.74M Sell
12,859
-916
-7% -$125K 0.03% 434
2024
Q1
$1.78M Buy
13,775
+130
+1% +$15.7K 0.03% 457
2023
Q4
$1.56M Sell
13,645
-101
-0.7% -$10.1K 0.03% 472
2023
Q3
$1.26M Buy
13,746
+648
+5% +$66.8K 0.03% 512
2023
Q2
$1.48M Buy
13,098
+1,798
+16% +$190K 0.03% 485
2023
Q1
$1.18M Sell
11,300
-164
-1% -$17.1K 0.03% 535
2022
Q4
$1.27M Buy
11,464
+463
+4% +$48.5K 0.03% 507
2022
Q3
$961K Sell
11,001
-73
-0.7% -$6.63K 0.03% 557
2022
Q2
$866K Sell
11,074
-490
-4% -$40.5K 0.02% 616
2022
Q1
$986K Sell
11,564
-1,270
-10% -$122K 0.02% 626
2021
Q4
$1.54M Buy
12,834
+1,530
+14% +$190K 0.03% 506
2021
Q3
$1.4M Sell
11,304
-70
-0.6% -$9.01K 0.03% 501
2021
Q2
$1.36M Buy
11,374
+280
+3% +$32K 0.03% 511
2021
Q1
$1.17M Sell
11,094
-210
-2% -$21.3K 0.03% 546
2020
Q4
$1.15M Sell
11,304
-806
-7% -$75.8K 0.03% 531
2020
Q3
$1.02M Sell
12,110
-460
-4% -$35.8K 0.03% 540
2020
Q2
$817K Sell
12,570
-1,449
-10% -$95.6K 0.02% 590
2020
Q1
$913K Sell
14,019
-5
-0% -$394 0.03% 482
2019
Q4
$1.1M Sell
14,024
-5,290
-27% -$412K 0.03% 532
2019
Q3
$1.54M Sell
19,314
-240
-1% -$18.9K 0.04% 435
2019
Q2
$1.64M Sell
19,554
-287
-1% -$22.9K 0.05% 440
2019
Q1
$1.57M Buy
19,841
+70
+0.4% +$5.11K 0.04% 440
2018
Q4
$1.32M Buy
19,771
+7,028
+55% +$486K 0.04% 469
2018
Q3
$1.02M Sell
12,743
-182
-1% -$13.6K 0.03% 602
2018
Q2
$871K Sell
12,925
-590
-4% -$42.8K 0.02% 653
2018
Q1
$1.04M Sell
13,515
-633
-4% -$46.8K 0.03% 599
2017
Q4
$965K Sell
14,148
-4,077
-22% -$271K 0.02% 652
2017
Q3
$1.14M Buy
+18,225
New +$1.09M 0.03% 572
2016
Q3
$1.14M Buy
+18,225
New +$894K 0.03% 572

Other funds holding XYL

Crossmark Global Holdings's XYL Position: Q2 2026 in Review

Crossmark Global Holdings increased its Xylem (XYL) stake by 1.2% in Q2 2026, buying an estimated $18.5K and bringing the position to 13,589 shares worth $1.61M. The position accounts for 0.02% of the portfolio, ranked #517.

Crossmark Global Holdings first reported a position in XYL in Q3 2016 and has held it in 37 quarters since. The position peaked at $1.84M in Q4 2025. 1,093 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Crossmark Global Holdings held 13,589 shares of Xylem worth $1.61M as of Q2 2026.
  • Crossmark Global Holdings bought 160 Xylem shares in Q2 2026, an estimated $18.5K.
  • Xylem made up 0.02% of Crossmark Global Holdings's portfolio in Q2 2026, its #517 holding.
  • Crossmark Global Holdings first reported a position in Xylem in Q3 2016 and has held it in 37 quarters since.
  • Crossmark Global Holdings's Xylem position peaked at $1.84M in Q4 2025.
  • 1,093 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Crossmark Global Holdings's 13F filing for Q2 2026, filed 16 Jul 2026.